The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma

Gynecologic Oncology

Volumn 65, Issue 3, 1997, Pages 493-498

  Chi, D S ^a   Mychalczak, B ^a   Saigo, P E ^a   Rescigno, J ^a   Brown, C L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; CLINICAL ARTICLE; FEMALE; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERUS CARCINOMA;

EID: 0031172699     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4676     Document Type: Article

References (21)

1. 1. Hannigan E, Curtin JP, Silverberg SG, Thigpen JT, Spanos WJ: Corpus: Mesenchymal tumors, in Hoskins WJ, Perez CA, Young RC (eds): Principles and Practice of Gynecologic Oncology. Philadelphia, Lippincott, 1992, pp 695-714
2. 2. Harlow BL, Weiss NS, Lofton S: The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76:399, 1986
3. 3. Vongtama V, Karlen JR, Piver SM, Tsukada Y, Moore RH: Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri. Am J Roentgenol 126:139-147, 1976
4. 4. Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein ML, Dunne ME, Rudolph JH: Uterine sarcomas. Analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 42:1161-1170, 1978
5. 5. Olah KS, Gee H, Blunt S, Dunn JA, Kelly K, Chan KK: Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 27:1095-1099, 1991
6. 6. Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, Yordan E, Brady MF: Prognostic factors in early-stage uterine sarcoma: A Gynecologic Oncology Group study. Cancer 71:1702-1709, 1993
7. 7. Spanos WJ, Peters LJ, Oswald MJ: Patterns of recurrence in malignant mixed mullerian tumor of the uterus. Cancer 57:155-159, 1986
8. 8. Vaccarello L, Curtin JP: Presentation and management of carcinosarcoma of the uterus. Oncology 6:45-49, 1992
9. 9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
10. 10. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
11. 11. Zar JH: Biostatistical Analysis, Englewood Cliffs, NJ, Prentice Hall, 1974
12. 12. DiSaia PJ, Castro JR, Rutledge FN: Mixed mesodermal sarcoma of the uterus. Am J Roentgenol 117:632-636, 1973
13. 13. Perez CA, Askin F, Baglan RJ, Kao MS, Kraus FT, Perez BM, Williams CF, Weiss D: Effects of irradiation on mixed mullerian tumors of the uterus. Cancer 43:1274-1284, 1979
14. 14. Hornback NB, Omura G, Major FJ: Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 12:2127-2130, 1986
15. 15. Larson B, Silfversward C, Nilsson B, Pettersson F: Mixed mullerian tumors of the uterus - prognostic factors: A clinical and histopathologic study of 147 cases. Radiother Oncol 17:123-132, 1990
16. 16. Echt G, Jepson J, Steel J, Lanholz B, Luxton G, Hernandez W, Astrahan M, Petrovich Z: Treatment of uterine sarcomas. Cancer 66:35-39, 1990
17. 17. Doss LL, Llorens AS, Henriquez AS: Carcinosarcoma of the uterus: A 40-year experience from the state of Missouri. Gynecol Oncol 18:43-53, 1984
18. 18. Dembo AJ: Radiotherapeutic management of ovarian cancer. Semin Oncol 11:238-250, 1984
19. 19. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A: Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus - a Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9:1-19, 1990
20. 20. Thigpen JT, Blessing JA, Orr JW Jr, DiSaia PJ: Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: A Gynecologic Oncology Group study. Cancer Treat Rep 70:271-274, 1986
21. 21. Sutton GP, Blessing JA, Rosenshein N, Photopulos G, DiSaia PJ: Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study). Am J Obstet Gynecol 161:309-312, 1989